Articles

Covid-19 vaccine immunogenicity in people living with HIV-1

Immunogenicity in each study group. Immunogenicity (anti-RBD IgG response) was measured by ELISA and reported in RLU (relative luminescence units) normalized to CR3022.
Elsevier,

Vaccine, Volume 40, 9 June 2022

COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. Although they have proven to be very effective in the general population, little is known about their efficacy in immunocompromised patients.
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Kaposi's sarcoma-associated herpes virus-derived microRNA K12–1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma

Elsevier,

SLAS Discovery, Volume 27, June 2022

Understanding the pathogenesis that leads to carcinogenesis of HIV-related gastrointestinal KS is essential for the treatment of diseases related to KSHV infection. This study strived to evaluate the effect of miR-K12–1 on the progression of HIV-related gastrointestinal KS.
Read more

SDG:

Goal 3: Good health and well-being
Global

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect

Elsevier,

Antiviral Research, Volume 202, June 2022

Nelfinavir is an HIV protease inhibitor that has been widely prescribed as a component of highly active antiretroviral therapy, and has been reported to exert in vitro antiviral activity against SARS-CoV-2. We here assessed the effect of Nelfinavir in a SARS-CoV-2 infection model in hamsters. 
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities
Global

Provider preferences for anal cancer prevention screening: Results of the International Anal Neoplasia Society survey

Elsevier,

Tumour Virus Research, Volume 13, June 2022

This study explores provider preferences regarding anal cancer screening indications, initiation age, tools, and referral threshold to high resolution anoscopy (HRA). Although consensus was lacking with regard to specific screening initiation age, more respondents recommended younger initiation ages for men who have sex with men (MSM) living with HIV (LWH) compared with MSM not LWH (p
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities
Global

Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults

Alluvial plots denote transitions in oral HPV infection status (any genotype) over the first four study visits in a) HIV+ and b) HIV- participants who had at least 2 valid HPV tests before loss to follow up or completion of 4th visit.
Elsevier,

Tumour Virus Research, Volume 13, June 2022

HIV has been shown to increase the likelihood of oral HPV infection. In this study, we evaluated the risk of oral HPV in HIV infected patients compared with HIV-negative controls.
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Tags:

HIV, Global

Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection

Elsevier,

Journal of Virus Eradication, Volume 8, June 2022

This research highlights the need for thorough informed consent procedures with assessment of comprehension and exploration of personal motives prior to enrollment in cure-related trials
Read more

SDG:

Goal 3: Good health and well-being; Goal 10: Reduced inequalities

Tags:

HIV, Global

Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021

Figure 1. Time-series, cross-sectional, and multivariate logistic regression analyses for vaccination hesitancy and uptake indicators
Elsevier,

The Lancet, Volume 399, 25 June 2022

This Article supports SDG 3 and 5 by exploring the indirect effects of COVID-19 on gender disparities globally, showing intensified levels of pre-existing widespread inequalities for a range of health, social, and economic indicators during the COVID-19 pandemic.
Read more

SDG:

Goal 3: Good health and well-being; Goal 5: Gender equality

Tags:

Gender equality and women's empowerment; Health and wellbeing; Diversity and inclusion, Global

Childbearing in radiology training and early career: Challenges, opportunities, and finding the best time for you

Elsevier,

Clinical Imaging, Volume 86, June 2022

This Editorial supports SDGs 3 and 5, exploring career-related challenges of childbearing and highlighting opportunities for radiologists in various career stages, so that they can make informed childbearing decisions.
Read more

SDG:

Goal 5: Gender equality; Goal 3: Good health and well-being

Tags:

Employment decent work for all and social protection; Health and wellbeing; Gender equality and women's empowerment, Global

Concordant physician-patient characteristics lose importance for Arab American women and their healthcare- cross-sectional study

Elsevier,

The Lancet Regional Health - Americas, Volume 10, June 2022

This Article supports SDGs 3, 5, and 10 focusing on the religious and cultural aspects that influence Arab American women's perspectives on health-care in the USA.
Read more

SDG:

Goal 3: Good health and well-being; Goal 5: Gender equality; Goal 10: Reduced inequalities

Tags:

Diversity and inclusion; Health and population, North America

The association between common urogenital infections and cervical neoplasia – A nationwide cohort study of over four million women (2002–2018)

Elsevier,

The Lancet Regional Health - Europe, Volume 17, June 2022

This Article supports SDGs 3 and 5, focusing on the association between common urogenital infections and cervical neoplasia in a cohort of women.
Read more

SDG:

Goal 3: Good health and well-being; Goal 5: Gender equality

Tags:

Health and wellbeing; Health and population, Europe

Pages